Topics: ACTA
Events
-
-
ACTA Advisory Council
-
ACTA International Clinical Trials Conference 2 – 5 October 2019
-
Clinical Trials 2020: National Tribute and Award Ceremony
-
ACTA Summit and Clinical Trials 2020 National Tribute and Award Ceremony
-
Clinical Trials 2021: National Tribute and Award Ceremony
-
Clinical Trials 2022: National Tribute and Awards
-
2022 ACTA ASM including the Australian Registry ASM
-
Clinical Trials (CT) Socials
-
ACTA STInG 3 part webinar series on Data Transparency (DT)
-
ACTA CEO update – August 2022
-
Improving clinical trial recruitment through innovative technologies
-
ACTA CEO update – October 2022
-
Clinical Quality Registries (CQR) SIG member webinar – Oct 2022
-
Economic evaluation alongside cluster trial webinar
-
Economic Evaluation Alongside Adaptive Trials webinar – 22 November
-
Sector consultations – online discussion with ACTA
-
ACTA 2023 International Clinical Trials Symposium
-
Webinar: National Clinical Trials Governance Framework: Update from sites that have been through accreditation
-
ACTA 2024 Trial of the Year Awards
-
ACTA 2024 Clinical Trials and Registries Symposium
-
ACTA 2025 Clinical Trials and Registries Symposium
News
-
Network managers join forces in new ACTA Special Interest Group
-
Call for new Members for ACTA’s Reference Groups
-
International leaders in Clinical Trials meet in Sydney
-
New ACTA Resources Brochure
-
ACTA celebrates successful International Clinical Trials Conference
-
Gala Dinner at Doltone House
-
Pre-Conference workshops
-
Workshop: Pragmatic randomised trial designs for evaluating health policy and practice change interventions
-
ACTA Annual General Meeting and Advisory Council Meeting
-
Conference speaker and Executive Director of CTTI releases recommendations for mobile technology trials
-
Gold Walkley recipient, Dr Norman Swan, confirmed as a speaker at ACTA Conference Gala Dinner
-
Health Economics 101 – designing cost-effectiveness studies alongside trials
-
Federal Minister for Health opening ACTA International Clinical Trials Conference
-
ACTA Member finds prostate cancer pill gives patients 30% better survival rate